1
Peter H. Wiernik, M.D.
Curriculum Vitae
CURRICULUM VITAE
Date of Preparation March 13, 2014
Name: Peter H. Wiernik, M.D.
Date and Place of Birth: June 16, 1939, Crockett, Texas
Citizenship: United States
Education: 1961 B.A. (with distinction), University of Virginia
1965 M.D., University of Virginia
Postdoctoral Training: 1965-66 Straight Medical Internship, Cleveland Metropolitan General Hospital, Western Reserve University, Cleveland, Ohio
1966-69 Fellow in Medical Oncology, National Cancer Institute
1969-70 Assistant Resident in Medicine, Cleveland Metropolitan General Hospital, Cleveland, Ohio
1970-71 Senior Resident in Medicine, Osler Service, Johns Hopkins Hospital, Baltimore, Maryland
Medical Licenses and Certification : New York, Maryland, and Virginia state licenses. Certified in Internal Medicine, ABIM 1973; Certified in Medical Oncology, ABIM Subspecialty Board of Medical Oncology, 1973.
Military Service: USPHS July 1966 – June 30, 1981
Professional Organizations and Societies:
American Association for the Advancement of Sciences, Elected to Fellowship, 1977
American Association for Cancer Research, 1970-Clinical Cancer Research Committee, 2002-2005
American College of Clinical Pharmacology, Elected to Fellowship, 1974; Member, Honors and Awards Committee, 1999-2002; Academia/Hospital Advisory Board, 2002- 2004; Credentials Committee, 2004- ; Member, Board of Regents 2012-17
American College of Physicians, Member l972, Fellow l974; MKSAP VII Hematology Committee, 1983-86, MKSAP 13, 16 and 17 reviewer.
American Federation for Medical Research, 1968-; Councilor, Eastern Division, 2010-13, Councilor at Large, National Council, 2011-2015, Chair-Elect, Eastern Division, 2013, Chair, Eastern Division, 201-15.
American Radium Society, 1981-; Member, Membership Credentials Committee,1984-89; Member, Scientific Program Committee, 1987-90; Member, Executive Committee, 1988-95; Member, Publications Committee, 1988-92, and Chairman, 1991-2; Member, Resident Awards Committee, 1990; Member, Nominating Committee, 1994-95; Member, Long Range Planning Committee, 1994-96. Elected Secretary, 1990-92; President-Elect, l992-93, President, 1993-94, Member, Scientific Program Committee, 2008-2009.
American Society of Clinical Oncology, 1970-; Member Program Committee 1972-73, 1976- 79 and 1989-90; Chairman, Committee on Cancer Education and Training 1976-79, and 1984-5; and Deputy Chairman 1983-84. Member, Nominating Committee, 1978; Chairman, Subcommittee on Clinical Investigation, 1980-1983, Member Publications Committee, 1985-91; Member, Public Issues Committee, 1991-94; Member Awards Selection Committee, 1996-2000; Member, Health Services Research Committee, 2000-2004; Program Committee, 2000; Reviewer, Lymphoma, ASCO Journal Review, ASCO OnLine, 2001-, Statesman Award, 2008.
American Society for Clinical Pharmacology and Therapeutics, 1981-
American Society of Hematology, 1970, Member Education Committee 1977-1979, Member Program Committee, 1982.
Association for Patient Oriented Research (founding member), 1999-2014. Membership committee 2010-2014, Board of Directors 2010-2014.
Association of Subspecialty Professors, 1994- ; Membership Committee, 2010-14.
Baltimore Blood Club, Program Committee, 1975-76, Chairman, 1976-77
European Association for Cancer Research, 1982-
Professional Organizations and Societies (cont.):
European Haematology Association, 1996-
European Society for Medical Oncology, 1996-
International Association for Comparative Research on Leukemia and Related Diseases, 1977 1985.
International Society for Experimental Hematology, 1975-
International Society of Hematology, Elected to Fellowship, 1972; International Advisory Committee, 1984-1994.
International Society for Preventive Oncology, 1982-
IntraScience Research Foundation, Associate Member, 1974-
Johns Hopkins Medical and Surgical Society, 1971-
New York Academy of Medicine, Fellow 1986-
New York Academy of Sciences, 1979-
New York Cancer Society, Inc., 1984-; Member, Program Committee, 1986-90.
Polish Society of Clinical Oncology, 1998-
Royal Society of Medicine (London), Affiliate, 1972, Elected to Fellowship, 1974-
Society for the Study of Blood, Member 1984-
Academic Appointments:
July 1971 - June 1974 Assistant Professor of Medicine, University of Maryland School of Medicine, Baltimore, MD
July 1974 - June 1976 Associate Professor of Medicine, University of Maryland School of Medicine, Baltimore, MD
July 1976- Oct. 1982 Professor of Medicine, University of Maryland School of Medicine, Baltimore, MD
July 1971 - Oct. l982 Instructor in Medicine (part-time) John Hopkins University School of Medicine, Baltimore, MD
Academic Appointments (cont.):
Oct. l982 - Oct. 1998 Gutman Professor of Oncology, Albert Einstein College of Medicine, New York, NY
July 1996 - Oct. 1998 Professor of Radiation Oncology, Albert Einstein College of Medicine, New York, NY
Oct. 1998 – July 2009 Professor of Medicine and Radiation Oncology, New York Medical College,
Valhalla, NY
Hospital Appointments:
July 1971-May 1976 Chief, Section of Medical Oncology, National Cancer Institute, Baltimore Cancer Research Program, Baltimore, Maryland
May 1976 - July 1981 Chief, Clinical Oncology Branch, National Cancer Institute, Baltimore Cancer Research Program, Baltimore, Maryland
Sept. l976 - July l98l Acting Associate Director for BCRP, Division of Cancer Treatment, National Cancer Institute, Baltimore, Maryland
July 1981 - Oct. l982 Director, Baltimore Cancer Research Center, University of Maryland, Baltimore, Maryland
Oct. l982 - Aug. 1993 Chief, Division of Medical Oncology, Albert Einstein College of Medicine; Associate Director for Clinical Research, Cancer Center, Albert Einstein College of Medicine; Chairman, Dept. Oncology, Montefiore Medical Center, New York, NY
Aug. 1993 - Oct. 1998 Associate Director for Clinical Research, Albert Einstein Cancer Center, Albert Einstein College of Medicine, New York, NY
Oct. 1998 - July 2008 Director, Comprehensive Cancer Center, Our Lady of Mercy Medical Center, New
York Medical College, New York, NY
Hospital Appointments (cont.)
July 2008 – May 2009 Director, Comprehensive Cancer Center,
Montefiore Medical Center-North Division,
Bronx, NY
Nov 2010 – Nov 2012 Director, Leukemia Program, Continuum Cancer Centers of New York, St. Lukes – Roosevelt Hospital Center, and Beth Israel Medical Center, New York, NY
Honors:
Undergraduate
Certificate of Intermediate Honors, University of Virginia College of Arts and Sciences, 1960
Phi Beta Kappa, 1961; Elected to Phi Beta Kappa Associates, 1991-
Z Society Award, University of Virginia, College of Arts and Sciences, 1961
Phi Sigma Society Undergraduate Award, University of Virginia College of Arts and Sciences, 1961
Medical School
Walter Reed Society Undergraduate Research Award, Univ of Va Medical School, 1964
Alpha Omega Alpha, University of Virginia Medical School, 1965
Byrd S. Leavell Hematology Award, University of Virginia Medical School, 1965
Later
American Medical Association Physicians Recognition Award, 1969-2006
American Society of Clinical Investigation, 1978-
Sigma Xi, 1979
Doctor Honoris Causa, Faculty of Medicine, University of the Republic, Montevideo, Uruguay, April 4, 1982.
Listed in Who's Who in the East, 1979-2014; Who's Who in America, 1980-2014; Who's Who in the World, 1980-2014; Who's Who in Science and Technology, 1984-1987; Who's Who in Cancer, 1985; Who's Who in Science and Engineering, 1994-2007; Who's Who in Medicine and Healthcare, 1998-2012, Who’s Who in Finance and Business, 2002-2007, Who’s Who in American Education, 2004-2007.
William F. Johnson Award, St. Joseph’s Hospital and Medical Center, Paterson, NJ, 1990.
Sociedad de Hematologia del Uruguay, elected to honorary membership1990
Harvey Society, Member 1991-
Polish Oncologic Society, elected to honorary membership l992
Honors (cont):
President, American Radium Society, 1992-93.
Janeway Medal, American Radium Society, 1996.
Osserman Award, Israel Cancer Research Fund, 1998.
First Foreign Corresponding Member, National Academy of Medicine of Uruguay, 1999
Gold Medal, First Congress of Polish Oncology, 2002.
Listed in “Guide to America’s Top Physicians, “ 2004-2014 editions
Statesman Award, American Society of Clinical Oncology, 2008.
Celgene Career Achievement Award for Clinical Research in Hematology, 2009.
Chair, Eastern Division, American Federation for Medical Research, 2014-15.
Fellowship and Grant Support
Past Support
1P50CA32107 - Specialized Center Support for a Cancer Research Center, P.H. Wiernik, principal investigator, $1,400,000 direct year 01. National Cancer Institute. 10/10/81- 10/09/82.
1R10CA31983 - Participation in CALGB, P.H. Wiernik, principal investigator, $61,224 direct year 01. National Cancer Institute. 4/1/82-3/31/83.
RD-142 - Research Development Program Grant to Baltimore Cancer Research Center, P.H. Wiernik principal investigator, $50,000 direct year 01. American Cancer Society. 10/10/81 - 10/09/82.
R01CA33164 - In vitro assay for predicting breast metastases, P.H. Wiernik, principal investigator, $82,147 direct year 0l. National Cancer Institute. 07/01/82-06/30/85.
5U10CA14958 - Participation in ECOG, P.H.Wiernik, principal investigator, $190,877 direct year 01. National Cancer Institute. 06/01/85-05/31/99.
5U10CA14958-S1 - ECOG supplement for enrollment of minorities in clinical trials, P.H. Wiernik, principal investigator, $32,197 direct year 01. National Cancer Institute. 06/01/85-05/31/93
Past Support (cont.)
5U10CA14958-S2 - ECOG supplement for IL-2/LAK cell studies in melanoma, colon cancer, and renal cell carcinoma, P.H. Wiernik, principal investigator, $442,506 direct year 01. National Cancer Institute. 02/01/86-01/31/87.
P30CA13330 - Core Support for Cancer Research Center, P.H. Wiernik, Associate Director for Clinical Research, $1,953,609 direct year 15 for clinical core program. National Cancer Institute. 06/01/82 - 10/06/99
NO1-CM-73705 - Clinical Trials of Activated Human Leukocytes, P.H. Wiernik, principal investigator, $624,759 direct year 01. National Cancer Institute. 06/30/87-06/29/91.
Einstein Dean's Award for New Initiatives in Collaborative Disease-Specific Research (1 of 10 awarded throughout the College): Molecular Genetics of Familial Hematologic Malignancies, - P.H. Wiernik and Jack Lenz, Co-P.I., $100,000/yr direct. 07/01/97-06/30/99.
Clinical Development of Arsenic Trioxide in Acute Leukemia, P.H. Wiernik, principal investigator, $100,000 direct year 01. Leukemia Society of America. 09/01/98-08/31/2001.
Frontier Science & Technology Research Foundation (subcontract from CA21115-24) - P.H. Wiernik, subcontract principal investigator. 05/01/98-04/30/99. $229,341 direct
1RO3CA79399-01- Phase II Study of Arsenic Trioxide in Leukemia, J.P. Dutcher, principal investigator, P.H. Wiernik, co-principal investigator, $50,000 direct year 01. National Cancer Institute. 07/01/98-06/30/2000.
Academic Medicine Development Company Foundation, Inc – Spiral CT Scan Screening of Heavy Smokers, P.H. Wiernik, principal investigator, $325,000 direct year 01. 09/01/00-08/31/02.
1U10CA91151-01- Minority-Based Community Clinical Oncology Program, P.H. Wiernik, principal investigator, $234,368 direct year 01. National Cancer Institute. 06/01/01-05/31/07
Numerous Pharmaceutical Industry Grants totaling over $8M 1974-present.
Present Support
Levine Family Foundation – General Support, P.H. Wiernik, principal investigator, $20,000/ year for 5 years 12/01/10 – 11/30/15
Pending Grants
Clinical trial negotiaitions with Celgene, Novartis and Bristol Meyers- Squibb in progress
Departmental and University Committees
University of Maryland
Member, Human Experimentation Committee 1974-5
Chairman, Cancer Committee 1977-82
Member, Radiotherapy Chair Search Committee 1978-80
Albert Einstein College of Medicine
Member, Credentials Committee, Dept. Medicine 1982-95
Member, Finance Committee, Dept. Medicine 1986-95
Chairman, Clinical Oncology Committee 1982-96
Member, Radiotherapy Chairman Search Committee 1982-3
Member, Pharmacology Chairman Search Committee 1983-4
Member, Committee on Promotions to Professor 1983-5; Co-Chairman, 1985-86, Chairman 1986-87
Member, Promotions Procedure Review Committee, 1989
Member, Pathology Chairman Search Committee, 1991
Member, Surgery Chairman Search Committee, 1991
Member, Executive Committee, Cancer Center, 1982-1993 and 1995-97
Member, CME Executive Committee, 1996-98
Montefiore Medical Center
Member, Clinical Research Center Advisory Committee 1982-84
Member, Research Committee 1982-88
Member, Institutional Review Board 1982-94
Chairman, Clinical Oncology Committee 1983-96
Member, Research Policy Advisory Committee 1984-94
Member, Medical Committee of the Board of Trustees 1986-93
Member, Medical Executive Committee, 1985-89
Member, Financial Advisory Committee to the Administration, 1990-94
Member, Pharmacy and Therapeutics Committee, 1996-98
Bronx Municipal Hospital Center
Chairman, Clinical Cancer Committee, 1984-96
Member, Pharmacy and Therapeutics Committee, 1984-98
Our Lady of Mercy Medical Center, New York Medical College
Member, Institutional Review Board, 1998-2009
Chair, Ad Hoc Faculty Committee on Finances, 2000
Member, Pharmacy and Therapeutics Committee, 2001-2009
Member, Annual Ball Physician’s Committee, 2005
Departmental and University Committees (cont.)
Beth Israel Medical Center
Institutional Review Board, Member 2011-2013
Teaching Experience and Responsibilities
1. Annual lecture on pharmacology of cancer drugs, University of Maryland School of Medicine, Second year students (approximately 100 students per class), 1971-1980.
2. Chairman, Sympossium on "Recent Advances in the Management of Disseminated Sarcoma," American Society of Clinical Oncology National Meeting, Atlantic City, NJ, April 10, 1973.
3. Chairman, Acute Leukemia Teaching Session, American Society of Hematology Meeting, Chicago, IL, December 1973.
4. Chairman, Oncology Teaching Session, American Society of Hematology, Atlanta, GA, 1974 and Dallas, TX, 1975
5. Faculty Member, ACP-ASH Course on Granulocyte Disorders at Colby College, Waterville, ME, July 1977
6. Faculty member, UICC Course on Cancer Chemotherapy, Montevideo, Uruguay, November 1977.
7. President, UICC Postgraduate Course on Antineoplastic Chemotherapy and Clinical Oncology, Buenos Aires, Argentina, April 23-28, 1979.
8. Visiting Professor, Center for Advanced Medical Studies, University of Alabama Medical School, Birmingham, AL, September 22-24, 1982
9. Course Director, Advances in Cancer Treatment, co-sponsored by Amer. Soc. Clin. Oncol. at National Amer. Coll. Phys. meeting, Philadelphia, PA, April 26-29, 1984.
10. Chairman, Educational Workshop on Allogeneic Bone Marrow Transplantation, Amer. Soc. Clinical Oncology, Houston TX, May 26, 1985
11. Visiting Professor in Hematology, Mayo Clinic, Rochester, MN, March 16-17, 1987.
12. Visiting Professor in Oncology, McGill University and University of Montreal, Montreal, Canada, February 20-21, 1996.
13. Visiting Professor, Institute of Hematology, University of Belgrade Medical School, Belgrade, Yugoslavia, June 12-18, 1996.
14. Chair Weekly Leukemia/Lymphoma Teaching Conference for housestaff and fellows (average attendance 25). CME accredited. 1982-2011
15. Attending on inpatient medical unit at Roosevelt Hospital, 1 month/yr 2011-2012
16. Physical Diagnosis Preceptor for Columbia students at Roosevelt hospital, 1 mo/yr 2011-2012.
17. Medical Oncology Fellowship Director, University of Maryland School of Medicine 1971-1983, Albert Einstein College of Medicine, 1983-1991, Our Lady of Mercy Medical Center (NY Medical College) 1991-1998
Other Professional Activities
a) Editorial Boards
Acta Haematologica Polonica, Member 1995-
American Journal of Clinical Oncology, Member, 1977-2003
American Journal of Medical Sciences, Co-editor, Oncology Rounds, 1976-82
American Journal of Therapeutics, Associate Editor for Oncology, 1994-2000
a) Editorial Boards (cont.)
Bilten Za Hematolohiju (journal of the Yugoslav Society of Hematology, 1998-2006
Cancer Research Bulletin, Member, 1984-85
Cancer Investigation, Associate Editor, 1988-1995; Section Co-Editor, Controversies In Patient Management 1985-1995; Co-Editor, Original Articles Section, 1998-2007
Cancer Treatment Reports, Co-editor, 1972-76
Faculty of 1000 Biology, Faculty Member 2007-
Hematology & Oncology, Member 2003-
Journal of Cancer Research and Clinical Oncology, Member 1983-86;
North American Editor, 1986-91
Journal of Clinical Medicine: Oncology, Editor-in-Chief, 2007-2010
Journal of Clinical Oncology, Member, 1989-1991. Consultant Editor, Diagnosis
In Oncology 2009-2013
Journal of Clinical Pharmacology, Section Editor, Oncology, 1985-2007
Journal of Neuro-Oncology, Member, 1989-2001
Leukemia, Member 1986-2003
Leukemia & Lymphoma 1989-2005
Leukemia Research, Member 1976-86, 1991- 2005
Leukemia Reviews International, Associate Editor, 1983-85
Medical Oncology, Associate Editor, 1987-93; Editor, 1993-2014.
Nowotwory, Member Editorial Board, 2001-
Oncologist's Clinical Update, Co-Editor, 1990-1995
Oncology News, Member, l992-2007
Open Leukemia Journal (The), 2008-
Polish Journal of Clinical Oncology, 1998-
Resident and Staff Physician, Member 1984-98
CPPCKИ APXИB (Serbian Archives of Medicine), Member 2005-
a) Manuscript Reviewer for:
Acta Haematologica
American Journal of Hematology
American Journal of Medicine
Annals of Internal Medicine
Annals of Oncology
Archives of Internal Medicine
Biotechnology Progress
Blood
Bone Marrow Transplantation
British Journal of Cancer
British Journal of Haematology